- $60.32m
- -$64.06m
- 23
- 49
- 47
- 33
Annual balance sheet for Ikena Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 162 | 232 | 157 | 175 | 124 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 166 | 237 | 160 | 179 | 127 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.56 | 8.98 | 8.46 | 8.02 | 4.23 |
| Other Long Term Assets | |||||
| Total Assets | 168 | 248 | 172 | 192 | 142 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 28.3 | 27.2 | 21.5 | 14.2 | 10.8 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 63.5 | 40 | 25.3 | 22.3 | 15.6 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 105 | 208 | 147 | 170 | 126 |
| Total Liabilities & Shareholders' Equity | 168 | 248 | 172 | 192 | 142 |
| Total Common Shares Outstanding |